Symphony Financial, Ltd. Co. Bristol Myers Squibb CO Transaction History
Symphony Financial, Ltd. Co.
- $608 Million
- Q3 2024
A detailed history of Symphony Financial, Ltd. Co. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Symphony Financial, Ltd. Co. holds 17,802 shares of BMY stock, worth $934,605. This represents 0.15% of its overall portfolio holdings.
Number of Shares
17,802
Previous 13,051
36.4%
Holding current value
$934,605
Previous $542,000
69.93%
% of portfolio
0.15%
Previous 0.1%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,435Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$9.79 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.33 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.8 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.92 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.1 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $112B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...